About this event
Airsonett and Dr Stephan Traidl cordially invite you to an exciting presentation of the results of the observational study Temperature-controlled laminar airflow in adult atopic dermatitis patients. The three-month observational study, with an extension phase of an additional 9 months, investigated the effect of an add-on treatment with TLA in 10 HDM-IgE-sensitized patients with moderate-to-severe AD and a history of clinically relevant house dust mite allergy.
We look forward to see you!
Airsonett offers effective treatment of allergic asthma and eczema – without pharmacological side effects. 99,5% allergen free air while you sleep
Share this event